Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo

INTRODUCTION: Ductal carcinoma in situ (DCIS) of the breast is a heterogeneous group of proliferative cellular lesions that have the potential to become invasive. Very little is known about the molecular alterations involved in the progression from DCIS to invasive ductal carcinoma (IDC). Heparan en...

Descripción completa

Detalles Bibliográficos
Autores principales: Khurana, Ashwani, McKean, Hiedi, Kim, Hyunseok, Kim, Sung-Hoon, Mcguire, Jacie, Roberts, Lewis R, Goetz, Matthew P, Shridhar, Viji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446377/
https://www.ncbi.nlm.nih.gov/pubmed/22410125
http://dx.doi.org/10.1186/bcr3140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446377/
https://www.ncbi.nlm.nih.gov/pubmed/22410125
http://dx.doi.org/10.1186/bcr3140

Ejemplares similares